INE0DK501011
INE0DK501011
PIRAMAL PHARMA LIMITED
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 260.87B EUR | 224.3B EUR | 180.88B EUR | 227.7B EUR |
Enterprise Value | 304.26B EUR | 224.3B EUR | 225.63B EUR | 227.7B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | 48.47x | -- | -- | -- |
Price to Sales | 2.83x | 3.13x | 2.65x | 3.33x |
Price to Book | 3.2x | -- | 2.22x | -- |
EV/Revenue | 3.31x | 3.13x | 3.31x | 3.33x |
EV/EBITDA | 33.89x | 20.88x | 23.65x | 21.62x |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -- | -- | -- | -- |